Treatment of Medication-Related Osteonecrosis of the Jaw : Controversies in Causality and Therapy - 09/11/23
![](/templates/common/images/mail.png)
Résumé |
Medication-related osteonecrosis of the jaw (MRONJ) is a most interesting, complex and “elusive” condition seen by the oral health care provider. It is plagued by controversy and although a wealth of research has created clinical treatment databases, there is no “gold standard” algorithm to be applied in a universal fashion. The purpose of this article is to explore several controversies associated with the etiology(s), staging, treatments, and long-term resolution of MRONJ in patients who are treated by the oral health care provider. Controversies for optimizing prevention, and disease control will also be discussed from an interdisciplinary perspective.
Le texte complet de cet article est disponible en PDF.Keywords : Medication-related osteonecrosis of the jaw, MRONJ, Antiresorptive drugs, Bisphosphonates, Denosumab, Controversy, MRONJ staging, Drug holiday
Plan
Vol 68 - N° 1
P. 67-85 - janvier 2024 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?